Q4 2019
Released Feb 27, 2020, after the close
10-K filed Feb 27, 2020, 58 days after period end · 0001493152-20-003069
Q4 2019 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$3.16M$3.16M derived+96.1% vs Q4 2018+2.1% vs Q3 2019
Net Income-$144.00K-$144.00K derivedN/M vs Q4 2018N/M vs Q3 2019
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$1,900,000+99.2%
Operating Incomederived-$291,000N/M
Operating Cash Flowderived$364,000N/M
Free Cash Flowderived$364,000—
Margins · derived
Gross margin60.1%+0.9 pt vs Q4 2018
Operating margin-9.2%+36.0 pt vs Q4 2018
Net margin-4.6%+40.4 pt vs Q4 2018
What the release said
The release
Same quarter
| Metric | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures |
|---|---|---|---|---|
| Revenue | $3.16M | $1.61M | $1.30M | $746.00K |
| Net Income | -$144.00K | -$725.00K | $1.29M | -$655.00K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR